In Other News

• Fitness Trackers Can Predict COVID-19 Infections, Suggests Landmark Study

• Moderna to Report Early Data from Ongoing COVID-19 Vaccine Trial in November

• Regeneron's COVID-19 Antibody Cocktail Significantly Reduces Virus Levels in Ongoing Phase 2/3 Trial

• More Than 90% of COVID-19 Patients Produce Strong Antibody Response to SARS-CoV-2 That Lasts for Many Months

• Global COVID-19 Diagnostics Market to Reach USD 9.94 Billion by Fourth Quarter of 2020

• New Technology Enables Touchless Respiratory and Heart Rate Measurement for COVID-19 Health Screening

• Non-Invasive COVID-19 Test Identifies `Breath Signatures` to Provide Almost Instant Results

• Designing COVID-19 Vaccine That Partially Mimics Structure Of SARS-CoV-2 Virus Could Increase Its Effectiveness

• Novartis Collaborates with Molecular Partners AG to Develop Antiviral Therapies for Prevention and Treatment of COVID-19

• New AI-Based Tool Rapidly and Automatically Determines Which COVID-19 Patients May Need Hospitalization

• World’s Fastest PCR-Based SARS-CoV-2 Test Now Available on Randox-Bosch Vivalytic POC Analyzer

• Discovery of Helpful and Harmful COVID-19-Related Genes to Aid Development of New Therapies

• Finger-Prick Tests Show Antibody Response to SARS-CoV-2 Reduces Over Time

• Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership

• Study to Examine Whether Rapid COVID-19 Antigen Tests Can Identify Infectious and Asymptomatic Individuals

• Ortho Launches New VITROS SARS-CoV-2 Antigen Test for Accurate Mass-Scale Testing in Markets Accepting CE Mark

• DiaSorin Launches New LIAISON SARS-CoV-2 Ag High-Throughput Antigen Test in Markets Accepting CE Mark

• AstraZeneca-Oxford COVID-19 Experimental Vaccine Triggers Similar Protective Antibodies and T-Cells in Both Older and Younger Adults

• New Groundbreaking COVID-19 Test to Identify SARS-CoV-2 Virus Particles in Exhaled Breath Within Five Minutes

• New Landmark Study Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients

• Inhaled Antibody from Convalescent COVID-19 Patients Could Be More Potent Treatment for SARS-Cov-2 Lung Infection

• PerkinElmer’s Multianalyte SARS-CoV-2, Flu Test Receives CE Mark

• CDC to Roll out Cell Phone-Based Surveillance System for Monitoring COVID-19 Vaccine Recipients